Latest Articles

Publication Date
Save over $600 on LG's dual-mode OLED gaming monitor - Mashable

Save over $600 on LG's dual-mode OLED gaming monitor Mashable

Published: Feb. 28, 2026, 11:24 p.m.
JLab Talk deal: Get it for $23.99 at Amazon - Mashable

JLab Talk deal: Get it for $23.99 at Amazon Mashable

Published: Feb. 28, 2026, 10:47 p.m.
Snag an 85-inch TCL Class T7 Series 4K TV for $400 less at Amazon - Mashable

Snag an 85-inch TCL Class T7 Series 4K TV for $400 less at Amazon Mashable

Published: Feb. 28, 2026, 6:43 p.m.
‘My Endometriosis was ignored for nearly 20 years – and now I rely on crutches’ - AOL.com

‘My Endometriosis was ignored for nearly 20 years – and now I rely on crutches’ AOL.com

Published: Feb. 28, 2026, 12:10 p.m.
Inside Amy Schumer’s Weight Loss Journey: Everything the Comedian Has Said About Her Health - AOL.com

Inside Amy Schumer’s Weight Loss Journey: Everything the Comedian Has Said About Her Health AOL.com

Published: Feb. 28, 2026, 9:07 a.m.
Get $50 off the Stealth 700 Gen 2 MAX gaming headset at Amazon - Mashable

Get $50 off the Stealth 700 Gen 2 MAX gaming headset at Amazon Mashable

Published: Feb. 27, 2026, 10 p.m.
ACR-368 in Serous Endometrial Cancer: Strong Phase 2b Efficacy, Manageable Safety, and a Clear Accelerated Approval Path Support Buy Rating on Acrivon - TipRanks

ACR-368 in Serous Endometrial Cancer: Strong Phase 2b Efficacy, Manageable Safety, and a Clear Accelerated Approval Path Support Buy Rating on Acrivon TipRanks

Published: Feb. 27, 2026, 7:47 p.m.
Pete Davidson’s girlfriend Elsie Hewitt says she has ‘inherent guilt’ for not breastfeeding their child - AOL.com

Pete Davidson’s girlfriend Elsie Hewitt says she has ‘inherent guilt’ for not breastfeeding their child AOL.com

Published: Feb. 27, 2026, 5:28 p.m.
Pete Davidson’s girlfriend Elsie Hewitt says she has ‘inherent guilt’ for not breastfeeding their child - inkl

Pete Davidson’s girlfriend Elsie Hewitt says she has ‘inherent guilt’ for not breastfeeding their child inkl

Published: Feb. 27, 2026, 5:14 p.m.
Acrivon Therapeutics Conference Highlights ACR-368 Phase 2B Data, 52% ORR in Serous Endometrial Cancer - MarketBeat

Acrivon Therapeutics Conference Highlights ACR-368 Phase 2B Data, 52% ORR in Serous Endometrial Cancer MarketBeat

Published: Feb. 27, 2026, 4:50 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!